Advances in Point-Of-Care Testing for Infectious Diseases

Presented At:
Infectious Disease Virtual Event 2019

Presented By:
Krishnan Allampallam, PhD - Global Marketing Director, Chembio Diagnostic Systems

Speaker Biography:
Krishnan Allampallam joined Chembio Diagnostic Systems, Inc about two years and serves as Global Director of Marketing. Krishnan has spent over 15+ years in the biotechnology industry. Before beginning his career in biotech, Krishnan focused his research in the field of oncology and has authored and co-authored multiple publications, abstracts and book chapters in peer reviewed journals. He received his Ph.D. from University of Toledo Medical Center in 1996 and did post-doctoral research at The Cleveland Clinic and Rush University Medical Center. Currently Krishnan is the Global Director of Marketing at Chembio Diagnostics, a New York Based public company focused on point of care rapid diagnostics. Prior to Chembio, Krishnan held various leadership positions in marketing and global product management.

Co-Presented By:
Paul Lambotte, PhD - Vice President, Research & Development, Chembio Diagnostic Systems

Speaker Biography:
Paul Lambotte joined Chembio Diagnostic Systems, Inc. in December 2014, and serves as Vice President of Product Development. Prior to joining the company, Mr. Lambotte was President of PLC Inc., a POC product development consulting company. He previously served as Chief Science Officer at Axxin Pty Ltd, held positions of VP of R&D and Business Development at Quidel Corporation, and held a number of positions at Beckman Coulter and Hybritech Inc. Mr. Lambotte is the inventor of several patents in the field of rapid, point-of-care diagnostic products. He received a Master in Biochemistry and a PhD in Protein Biochemistry from the University of Mons, Belgium, and did post-doctoral work at the Ludwig Institute for Cancer research in Brussels, Belgium.

Webinar:
Advances in Point-Of-Care Testing for Infectious Diseases

Webinar Abstract:
Point-of-care testing (POCT) is diagnostic testing at the time and place of patient care in a physician’s office, an ambulance, a mobile clinic, at home or in hospital. Rapid POC testing yields actionable results and rapid treatment of patients. Until now, POC tests based on lateral flow technology have suffered of limitations in sensitivity, specificity, the lack of multiplexing and the questionable reliability of results obtained visually by the users. To address these limitations, Chembio has developed an advanced rapid POC testing solution, the DPP® System combining its Dual Path Platform (DPP®) disposable cartridges with its optical analyzer (DPP® Reader). The DPP® System provides users with a complete solution for rapid testing at the Point of Care. The DPP® System requires one small sample from the patient, minimum hands-on time, short turn-around time, and provides multiple results in one operation, free from human bias. During the webinar “Advances in POC Testing for infectious diseases”, we will introduce the advanced DPP® technology, the optical analyzer, and demonstrate the power of the DPP® Systems in detecting multiple biomarkers at the Point of Care.

Learning Objectives:
1. Current needs and status of POC diagnostics in infectious diseases
2. What is DPP technology and how it differs from the current lateral flow technology
3. Application of DPP technology in multiplex testing
4. How the combination of DPP technology and a hand held digital reader in POC testing improves testing accuracy

Earn PACE Credits:

LabRoots on Social:
SnapChat: labroots_inc